These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3504057)

  • 1. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Steroids; 1987; 50(1-3):135-46. PubMed ID: 3504057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Breast Cancer Res Treat; 1993; 26(1):15-21. PubMed ID: 8400320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
    J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione.
    Brandt ME; Puett D; Covey DF; Zimniski SJ
    J Steroid Biochem; 1988 Sep; 31(3):317-24. PubMed ID: 3419162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human trophoblast xenografts in athymic mice: a model for peripheral aromatization.
    Johnston JO; Wright CL; Shumaker RC
    J Steroid Biochem; 1989 Oct; 33(4A):521-9. PubMed ID: 2811362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of in vivo administration of 10-propargylestr-4-ene-3,17-dione on rat ovarian aromatase and estrogen levels.
    Brandt ME; Covey DF; Zimniski SJ
    J Enzyme Inhib; 1990; 4(2):143-52. PubMed ID: 2098521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of 10-(2-propynyl) estr-4-ene-3, 17-dione (MDL 18,962), an enzyme-activated inhibitor of aromatase.
    Johnston JO
    Steroids; 1987; 50(1-3):105-20. PubMed ID: 2847370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors.
    Rowlands MG; Foster AB; Mann J; Pietrzak B; Wilkinson J; Coombes RC
    Steroids; 1987; 49(4-5):371-82. PubMed ID: 3455049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH
    Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Leydig tumor cell steroidogenesis by 10-propargylestr-4-ene-3,17-dione, an irreversible aromatase inhibitor.
    Zimniski SJ; Brandt ME; Melner MH; Covey DF; Puett D
    Cancer Res; 1985 Oct; 45(10):4883-9. PubMed ID: 4027975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of thiol-containing androgens with human placental aromatase.
    Bednarski PJ; Nelson SD
    J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of rat Leydig tumor (R2C) and human hepatoma (HEPG2) cells to evaluate potential inhibitors of rat and human steroid aromatase.
    Doody KM; Murry BA; Mason JI
    J Enzyme Inhib; 1990; 4(2):153-8. PubMed ID: 1965908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel irreversible aromatase inhibitors.
    di Salle E; Giudici D; Briatico G; Ornati G
    Ann N Y Acad Sci; 1990; 595():357-67. PubMed ID: 2375613
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase.
    Johnston JO; Wright CL; Metcalf BW
    Endocrinology; 1984 Aug; 115(2):776-85. PubMed ID: 6745181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of 19-(ethyldithio)-androst-4-ene-3,17-dione (ORG 30958): a potent aromatase inhibitor in vivo.
    Geelen JA; Deckers GH; van der Wardt JT; Loozen HJ; Tax LJ; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):181-8. PubMed ID: 1825923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione.
    Brodie AM; Marsh D; Brodie HJ
    J Steroid Biochem; 1979 Apr; 10(4):423-9. PubMed ID: 109701
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors.
    Abul-Hajj YJ
    J Steroid Biochem; 1989; 34(1-6):439-42. PubMed ID: 2516585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
    Zaccheo T; Giudici D; Lombardi P; di Salle E
    Cancer Chemother Pharmacol; 1989; 23(1):47-50. PubMed ID: 2491793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives.
    Marsh DA; Brodie HJ; Garrett W; Tsai-Morris CH; Brodie AM
    J Med Chem; 1985 Jun; 28(6):788-95. PubMed ID: 4009601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.